title: Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis.
authors.affiliation: Institute of Immunology, University of Heidelberg, Heidelberg, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Wehling
authors.forename: M
authors.initials: M
authors.lastname: Kirschfink
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome / Q000188:drug therapy*; D003176:Complement C3 / Q000037:antagonists & inhibitors*; D003182:Complement C5 / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003176:Complement C3; D003182:Complement C5; C481642:eculizumab